← Back to headlines
Wall Street Pivots Investment Focus to Baldness Drug Market Over GLP-1 Stocks
Market analysts are redirecting capital toward pharmaceutical developers targeting pattern hair loss, forecasting stronger returns compared to the saturated GLP-1 weight-loss sector.
29 Aug, 14:35 — 29 Aug, 15:11
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (24/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 1/5 buckets covered0/33
Far L
Left
Center2
Center (2)
fortunemoneycontrol
Right
Far R
Geographic diversity— 2 regions9/34
US1India1
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
fortune2d ago
Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
Pattern hair loss affects an estimated 50 million men and 30 million women in the US, but there have been no new approved drugs since the late 1990s.
By Avalon Pernell, Lisa Pham, Bloomberg
Read full article →moneycontrol2d ago
Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine - Moneycontrol.com
Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine Moneycontrol.com
Read full article →Coverage Timeline
First report: moneycontrol · 29 Aug, 14:35|Full coverage: 2 · 36m|Window: 36m
Left-leaningCenterRight-leaning
